Peripheral Vascular Disease Stocks List

Recent Signals

Date Stock Signal Type
2021-04-16 ANGO NR7 Range Contraction
2021-04-16 ANGO Doji - Bearish? Reversal
2021-04-16 ANGO New 52 Week Closing High Bullish
2021-04-16 BSX Upper Bollinger Band Walk Strength
2021-04-16 BSX Cup with Handle Other
2021-04-16 LMAT Narrow Range Bar Range Contraction
2021-04-16 LMAT NR7 Range Contraction
2021-04-16 LMAT NR7-2 Range Contraction
2021-04-16 LNTH MACD Bullish Signal Line Cross Bullish
2021-04-16 LNTH New 52 Week High Strength
2021-04-16 LNTH Stochastic Reached Overbought Strength
2021-04-16 MMSI Slingshot Bullish Bullish Swing Setup
2021-04-16 MMSI New 52 Week Closing High Bullish

Recent News for Peripheral Vascular Disease Stocks

Date Stock Title
Apr 17 BSX BOSTON SCIENTIFIC INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Boston Scientific Corporation - BSX
Apr 16 ANGO AngioDynamics (ANGO) Presents At 20th Annual Needham Virtual Healthcare Conference - Slideshow
Apr 16 MMSI Lifshitz Law Firm, P.C. Announces Investigations of Inovio Pharmaceuticals, Inc. (NasdaqGS: INO), Merit Medical Systems, Inc. (NasdaqGS: MMSI), RCI Hospitality Holdings, Inc. (NasdaqGM: RICK), and Vanda Pharmaceuticals, Inc. (NasdaqGS: VNDA)
Apr 16 ITGR Globus Medical (GMED) Simplifies Spine Surgery With CREO ONE
Apr 15 BSX 'Halftime Report' Final Trades: Apple, Nvidia And More
Apr 15 MMSI Dental Market Shows Strength Despite Pandemic: 3 Stocks to Watch
Apr 14 LMAT LeMaitre Will Announce First Quarter 2021 Earnings Results on April 29, 2021
Apr 14 LMAT Thermo Fisher (TMO) Gets EUA for Amplitude/TaqPath COVID-19 Kit
Apr 13 MMSI The Law Offices of Frank R. Cruz Announces Investigation of Merit Medical Systems, Inc. (MMSI) on Behalf of Investors
Apr 13 MMSI Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Merit Medical Systems, Inc. (MMSI) on Behalf of Investors
Apr 13 LMAT Thermo Fisher (TMO) Rides on End Markets as Pandemic Rages On
Apr 13 LMAT Medtronic's (MDT) GI Genius Module Gets FDA De Novo Clearance
Apr 12 MMSI INVESTOR ALERT: Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Merit Medical Systems, Inc.
Apr 12 BSX Boston Scientific Corporation -- Moody's announces completion of a periodic review of ratings of Boston Scientific Corporation

Peripheral artery disease (PAD) is an abnormal narrowing of arteries other than those that supply the heart or brain. When narrowing occurs in the heart, it is called coronary artery disease, and in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms include skin ulcers, bluish skin, cold skin, or abnormal nail and hair growth in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke. Up to 50% of people with PAD do not have symptoms.The greatest risk factor for PAD is cigarette smoking. Other risk factors include diabetes, high blood pressure, kidney problems, and high blood cholesterol. The most common underlying mechanism of peripheral artery disease is atherosclerosis, especially in individuals over 40 years old. Other mechanisms include artery spasm, blood clots, trauma, fibromuscular dysplasia, and vasculitis. PAD is typically diagnosed by finding an ankle-brachial index (ABI) less than 0.90, which is the systolic blood pressure at the ankle divided by the systolic blood pressure of the arm. Duplex ultrasonography and angiography may also be used. Angiography is more accurate and allows for treatment at the same time; however, it is associated with greater risks.It is unclear if screening for peripheral artery disease in people without symptoms is useful as it has not been properly studied. In those with intermittent claudication from PAD, stopping smoking and supervised exercise therapy improve outcomes. Medications, including statins, ACE inhibitors, and cilostazol may also help. Aspirin does not appear to help those with mild disease but is usually recommended in those with more significant disease due to the increased risk of heart attacks. Anticoagulants such as warfarin are not typically of benefit. Procedures used to treat the disease include bypass grafting, angioplasty, and atherectomy.In 2015, about 155 million people had PAD worldwide. It becomes more common with age. In the developed world, it affects about 5.3% of 45- to 50-year-olds and 18.6% of 85- to 90-year-olds. In the developing world, it affects 4.6% of people between the ages of 45 and 50 and 15% of people between the ages of 85 and 90. PAD in the developed world is equally common among men and women, though in the developing world, women are more commonly affected. In 2015 PAD resulted in about 52,500 deaths, which is an increase from the 16,000 deaths in 1990.

More about Peripheral Vascular Disease
Browse All Tags